nafazatrom has been researched along with 6-ketoprostaglandin f1 alpha in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhle, YS; Pankhania, JJ | 1 |
| Angus, JA; Crabb, DJ; Knight, KR; Martin, TJ; Niall, M; O'Brien, BM | 1 |
| Mehta, J; Mehta, P; Roy, L | 1 |
| Bennett, A; Carroll, MA; Corrigan, CJ; Melhuish, PB; Patel, S; Stamford, IF | 1 |
| Bayorh, MA; Faden, AI; Feuerstein, G; Goldstein, DS; Ramwell, PW; Stull, R; Zerbe, RL | 1 |
| Fiedler, VB; Grützmann, R; Mardin, M; Perzborn, E | 1 |
| Hillyard, CJ; Martin, TJ; Nolan, RD; Partridge, NC | 1 |
| Coker, SJ; Parratt, JR | 1 |
| Myatt, L; Williams, HJ; Young, KD | 1 |
| Fischer, S; Struppler, M; Weber, PC | 1 |
1 trial(s) available for nafazatrom and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease.
Topics: 6-Ketoprostaglandin F1 alpha; beta-Thromboglobulin; Blood Pressure; Coronary Disease; Exercise Test; Female; Fibrinolytic Agents; Heart Rate; Humans; Male; Middle Aged; Platelet Count; Platelet Factor 4; Pyrazoles; Pyrazolones; Thromboxane B2 | 1985 |
9 other study(ies) available for nafazatrom and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Drug effects on output of prostacyclin from isolated lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Dipyridamole; Epoprostenol; Guinea Pigs; In Vitro Techniques; Lung; Male; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains | 1987 |
Pharmacologic modification of blood flow in the rabbit microvasculature with prostacyclin and related drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Abdominal Muscles; Animals; Blood Flow Velocity; Blood Pressure; Cyclooxygenase Inhibitors; Epoprostenol; Imidazoles; Indomethacin; Microcirculation; Platelet Aggregation; Pyrazoles; Pyrazolones; Rabbits; Regional Blood Flow; Surgical Flaps; Thromboxane-A Synthase; Vasoconstriction; Vasodilation | 1985 |
Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antineoplastic Agents; Female; Imidazoles; Mammary Neoplasms, Experimental; Mice; Prostaglandins E; Pyrazoles; Pyrazolones; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine Vasopressin; Blood Pressure; Epinephrine; Fibrinolytic Agents; Heart Rate; Male; Norepinephrine; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; SRS-A; Thromboxane B2 | 1985 |
The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Electrocardiography; Female; Male; Myocardial Infarction; Perfusion; Platelet Aggregation; Pyrazoles; Pyrazolones; Thromboxane B2 | 1985 |
Regulation of prostaglandin production by osteoblast-rich calvarial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Bradykinin; Cells, Cultured; Dexamethasone; Dinoprostone; Epidermal Growth Factor; Imidazoles; Indomethacin; Osteoblasts; Prostaglandins; Prostaglandins E; Pyrazoles; Pyrazolones; Rats; Thrombin | 1985 |
The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
Topics: 6-Ketoprostaglandin F1 alpha; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epoprostenol; Female; Fibrinolytic Agents; Male; Perfusion; Prostaglandins; Pyrazoles; Pyrazolones; Thromboxane B2 | 1984 |
Thrombotic thrombocytopenic purpura: treatment with nafazatrom.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Epoprostenol; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Pyrazoles; Pyrazolones | 1984 |
In vivo and in vitro effects of nafazatrom (Bay g 6575), an antithrombotic compound, on arachidonic acid metabolism in platelets and vascular tissue.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acids; Blood Platelets; Blood Vessels; Fibrinolytic Agents; Humans; Kidney Cortex; Male; Microsomes; Middle Aged; Platelet Aggregation; Platelet Count; Pyrazoles; Pyrazolones; Thromboxane B2 | 1983 |